A Study With Neoadjuvant mFOLFOX7 Plus Cetuximab to Determine the Surgical Conversion Rate for Unresectable Colorectal Cancer With Metastases Confined to the Liver
This study is ongoing, but not recruiting participants.
Study NCT00803647
Information provided by National Surgical Adjuvant Breast and Bowel Project (NSABP)
First Received on December 4, 2008.
Last Updated on April 24, 2013
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
